These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19088040)

  • 41. Increased levels of tissue endostatin in human malignant gliomas.
    Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
    Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical expression of ATRX in gliomas.
    Jalal JA; Rowandizy AIS; Ismael AT
    Cell Mol Biol (Noisy-le-grand); 2020 Aug; 66(7):131-135. PubMed ID: 33287933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression and significance of ABCG2 in human malignant glioma].
    Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
    Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
    Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
    Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas.
    Yamaguchi S; Kobayashi H; Terasaka S; Ishii N; Ikeda J; Kanno H; Nishihara H; Tanaka S; Houkin K
    Jpn J Clin Oncol; 2012 Apr; 42(4):270-7. PubMed ID: 22399670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
    Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
    J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of tissue factor in glioma.
    Hamada K; Kuratsu J; Saitoh Y; Takeshima H; Nishi T; Ushio Y
    Noshuyo Byori; 1996 Nov; 13(2):115-8. PubMed ID: 8958516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epithelial differentiation in gliomas, meningiomas and choroid plexus papillomas.
    Cruz-Sánchez FF; García-Bachs M; Rossi ML; Rodríguez-Prados S; Ferrer I; Coakham HB; Ferreres JC; Figols J; Palacin A
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):25-34. PubMed ID: 1352072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.
    Elsir T; Edqvist PH; Carlson J; Ribom D; Bergqvist M; Ekman S; Popova SN; Alafuzoff I; Ponten F; Nistér M; Smits A
    Int J Cancer; 2014 Mar; 134(5):1123-31. PubMed ID: 24037901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and prognostic significance of epilepsy in patients with gliomas.
    Lote K; Stenwig AE; Skullerud K; Hirschberg H
    Eur J Cancer; 1998 Jan; 34(1):98-102. PubMed ID: 9624245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. STAT3 tyrosine phosphorylation influences survival in glioblastoma.
    Birner P; Toumangelova-Uzeir K; Natchev S; Guentchev M
    J Neurooncol; 2010 Dec; 100(3):339-43. PubMed ID: 20455003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downregulation of GRIM-19 promotes growth and migration of human glioma cells.
    Zhang Y; Hao H; Zhao S; Liu Q; Yuan Q; Ni S; Wang F; Liu S; Wang L; Hao A
    Cancer Sci; 2011 Nov; 102(11):1991-9. PubMed ID: 21827581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression of nm23 and proliferating cell nuclear antigen (PCNA) in human brain gliomas and their significance].
    Tan PG; Li ZQ; Cai WQ; Lu JP; Xie FS; Weng Y
    Ai Zheng; 2003 Oct; 22(10):1077-80. PubMed ID: 14558955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunocytochemical detection of p53 in human gliomas.
    Bruner JM; Saya H; Moser RP
    Mod Pathol; 1991 Sep; 4(5):671-4. PubMed ID: 1758878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of interleukin-1beta mRNA and protein in human gliomas assessed by RT-PCR and immunohistochemistry.
    Sasaki A; Tamura M; Hasegawa M; Ishiuchi S; Hirato J; Nakazato Y
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):653-63. PubMed ID: 9690669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
    Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
    Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
    [No Abstract]   [Full Text] [Related]  

  • 60. Twist predicts poor outcome of patients with astrocytic glioma.
    Nordfors K; Haapasalo J; Mäkelä K; Granberg KJ; Nykter M; Korja M; Paavonen T; Haapasalo H; Soini Y
    J Clin Pathol; 2015 Nov; 68(11):905-12. PubMed ID: 26163539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.